close

Chandra Bhagat Pharma Ltd

Know More
NSEBSE
Stock not tradded

110.000.00 (0.00%)

04:01 PM,28th Sep 2023

BSE : 542934

NSE :

Sector : Others

ISIN Code : INE07QQ01016

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 28 2023 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Limited was incorporated as a private limited company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20 2019.Inspirited by its founder Late Shree Chandravadan Bhagat's sense of personal mission the company is driven to fill the gap in pharma sector especially in critical lifesaving medicines in India. The Company was incorporated on March 10 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1 2003 the company acquired the going concern business of M/s. Chandra Bhagat Corporation ('partnership firm') along with all its assets and liabilities. Consequently the company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation against the acquisition of going concern business along with all its assets and liabilities. The promoter Mr. Hemant Bhagat decided to continue on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics Antineoplastic Cardiovascular Hormones etc. and set up the company's marketing force in order to wider the product portfolio. Subsequently in the year 2004 the promoter Mr. Pranav Bhagat son of Mr. Hemant Bhagat being third generation also joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.The promoters have a combined experience of more than 41 years in the Pharmaceutical products Bulk drugs and vaccines. Driven by the passion for building an integrated pharmaceutical company backed by their more than two decades of experience the Promoters have been the pillars of the Company's growth since inception and have built a strong value system for the Company. With their enriching experience and progressive thinking the company aims to continue to grow in the pharmaceutical and bulk drugs in India and abroad.

Chandra Bhagat Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

83

EPS - TTM (₹) [S]

1.20

P/E Ratio (X) [S]

3.02

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]36.42
P/B Ratio (₹) [S]3.02
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

103.00

111.00

Week Low/High

103.00

133.00

Month Low/High

103.00

137.00

Year Low/High

83.00

149.00

All time Low/High

30.50

149.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-5.17%%-0.27-0.18%
1 Month-15.06%%1.161.53%
3 Month-15.38%%2.993.51%
6 Month%%14.2615.85%
1 Year%%16.7016.77%
3 Year214.29%%73.3574.99%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
11-08-2023CHANAKYA OPPORTUNITIES FUND IBSEBUY67000137.15
08-08-2023V JOSHI IMPEX PRIVATE LIMITEDBSESELL43000118.87
10-04-2023BEELINE MERCHANT BANKING PRIVATE LIMITEDBSEBUY6900097.00
10-04-2023SAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDBSESELL6900097.00
31-03-2023BEELINE MERCHANT BANKING PRIVATE LIMITEDBSESELL6800097.00
31-03-2023SAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDBSEBUY6800097.00
23-02-2023HEMANT CHANDRAVADAN BHAGATBSESELL49000100.43
23-02-2023PRASHANT A THAKKAR HUFBSEBUY49000100.43
02-09-2022NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDBSEBUY45000100.00
02-06-2022ADITYA ENTERPRISEBSEBUY134000105.00

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter68.24
Financial Institutions Banks0.00
Foreign Institutional Investors0.85
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public18.98
Others Non Institutional Investors11.93
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Managing Director : Hemant C Bhagat

Whole-time Director : Pranav H Bhagat

Director & CFO : Prachi Pranav Bhagat

Independent Director : Ravindra Gajanan Awati

Independent Director : Abha Praveen Doshi

Registered Office: 323-F Bhagat Bhuvan, Dr Ambedkar Road Matunga (E),Mumbai,Maharashtra-400019 Ph: 91-22-24146154

Email:compliance@cbcpharma.net

URL:http://www.cbcpharma.com